Table 2

Change in Outcomes From Baseline to Follow-Up

Change From Baseline
OutcomeApp-Treatment (n = 102)aCare as Usual (n = 93)Adjusted Difference (95% CI) or P Value
ICIQ-UI-SF score, mean (SD)-2.16 (2.56)-2.56 (3.51)0.058 (-0.776 to 0.891)
ICIQ-LUTS-QoL score, mean (SD)-4.34 (5.44)-3.78 (5.90)-0.566 (-2.035 to 0.902)
PGI-I, No. (%)P = .35b
    Very much better2 (2.0)11 (11.8)
    Much better25 (24.5)20 (21.5)
    A little better40 (39.2)31 (33.3)
    No change30 (29.4)26 (28.0)
    A little worse3 (2.9)2 (2.2)
    Much worse2 (2.0)3 (3.2)
    Very much worse
UI episodes per day-0.61 ± 2.02-0.48 ± 1.20P = .71b
  • app = application; ICIQ-LUTS-QoL = International Consultation on Incontinence Modular Questionnaire lower urinary tract symptoms quality of life; ICIQ-UI-SF = ICIQ Urinary Incontinence Short Form; PGI-I = patient global impression of improvement; UI = urinary incontinence.

  • Notes: Number for analysis ranged from 83 to 102 for the app-treatment group and from 74 to 93 for the care as usual group. Analyses performed on an intention-to-treat basis. ICIQ-UI-SF score and ICIQ-LUTS-QoL score are adjusted for baseline. PGI-I and UI (per day) are unadjusted scores.

  • aA baseline questionnaire was missing for 1 patient in the app-treatment group for the outcomes of ICIQ-UI-SF score and ICIQ-LUTS-QoL score.

  • bAssessed with the U statistic.